3 results
Approved WMOWill not start
The primary objective of this study is to determine if ambrisentan is effective in delaying disease progression and death in subjects with IPF.Secondary objectives include evaluation of the safety and effect of ambrisentan on development of…
Approved WMOCompleted
To examine the effects of mono- and combination therapy with linagliptin and empagliflozine on renal hemodynamics
Approved WMOCompleted
To gain more knowledge about the effects of SGLT2 inhibition on renal hemodynamics and the underlying mechanisms.